We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$5.04B
AUM Growth
-$1.51B
Cap. Flow
-$1.73B
Cap. Flow %
-34.29%
Top 10 Hldgs %
28.18%
Holding
958
New
171
Increased
45
Reduced
92
Closed
231

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$161M
2
AMZN icon
Amazon
AMZN
+$62.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$51.8M
4
MTG icon
MGIC Investment
MTG
+$48.3M
5
DXCM icon
DexCom
DXCM
+$33M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$98.6M
2
MRNA icon
Moderna
MRNA
+$73.1M
3
CNI icon
Canadian National Railway
CNI
+$72.9M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$69.7M
5
CPNG icon
Coupang
CPNG
+$60.8M

Sector Composition

Rank Sector Weight
1 Financials 25.56%
2 Technology 10.69%
3 Consumer Discretionary 9.59%
4 Industrials 9.05%
5 Healthcare 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRPB.WS
501
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
$340K 0.01%
250,000
– –
CORS.WS
502
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$337K 0.01%
333,333
– –
SEAH.WS
503
DELISTED
Sports Entertainment Acquisition Corp. Redeemable Warrants, each whole Warrant exercisable for one s
SEAH.WS
$325K 0.01%
125,000
– –
CONXW
504
DELISTED
CONX Corp. Warrant
CONXW
$323K 0.01%
375,000
– –
RNWWW
505
ReNew Energy Global PLC Warrant
RNWWW
$61.1K
$310K 0.01%
200,000
– –
IPOD.WS
506
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$306K 0.01%
150,000
– –
PNTM.WS
507
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$297K 0.01%
333,333
– –
AVAN.WS
508
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$296K 0.01%
500,000
– –
EMBKW
509
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$294K 0.01%
150,000
-50,000
-25% -$74.7K
BHC icon
510
Bausch Health
BHC
$2.62B
$276K 0.01%
10,000
-10,000
-50% -$268K
RBOT.WS
511
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$269K 0.01%
125,000
– –
CPAAW
512
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$260K 0.01%
+250,000
New +$250K
SVFAW
513
DELISTED
SVF Investment Corp. Warrant
SVFAW
$260K 0.01%
200,000
– –
OCAX
514
DELISTED
OCA Acquisition Corp. Class A Common Stock
OCAX
$248K ﹤0.01%
25,000
– –
AFTR.WS
515
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
$233K ﹤0.01%
+333,333
New +$273K
IVAN.WS
516
DELISTED
Ivanhoe Capital Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
IVAN.WS
$233K ﹤0.01%
133,333
– –
IPG
517
DELISTED
Interpublic Group of Companies
IPG
$232K ﹤0.01%
6,198
-141,798
-96% -$5.16M
OLN icon
518
Olin
OLN
$2.12B
$230K ﹤0.01%
4,000
-221,485
-98% -$12.4M
TWCBW
519
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
$230K ﹤0.01%
250,000
– –
CTAQW
520
DELISTED
Carney Technology Acquisition Corp. II Warrant
CTAQW
$230K ﹤0.01%
333,333
– –
ASPCW
521
DELISTED
Alpha Capital Acquisition Co Warrant
ASPCW
$214K ﹤0.01%
250,000
– –
HAACW
522
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$211K ﹤0.01%
250,000
– –
CSTA.WS
523
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$210K ﹤0.01%
333,333
– –
NOACW
524
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
$210K ﹤0.01%
500,000
– –
EQRXW
525
DELISTED
EQRx, Inc. Warrant
EQRXW
$208K ﹤0.01%
200,000
– –
19 20
21
22 23

Similar funds

SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return

Moore Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Moore Capital Management held 958 positions worth $5.04B, down 23% from $6.55B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Moore Capital Management withdrew a net $1.73B in Q4 2021, closing 231 positions and reducing 92 holdings. Its most notable exit was Moderna, an estimated $73.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Moore Capital Management opened a new position in State Street SPDR S&P Biotech ETF worth $150M.

  • Moore Capital Management's largest Q4 2021 buy was State Street SPDR S&P Biotech ETF: 1,335,600 shares worth $150M.
  • Moore Capital Management added most to Amazon in Q4 2021, an estimated $62.2M increase.
  • Moore Capital Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $98.6M.
  • Moore Capital Management fully exited Moderna in Q4 2021, selling an estimated $73.1M.
  • Moore Capital Management's ten largest holdings make up 28% of its $5.04B portfolio in Q4 2021.
  • Moore Capital Management opened 171 new positions and closed 231 in Q4 2021.
  • Moore Capital Management's portfolio value fell 23% quarter-over-quarter to $5.04B.

Based on Moore Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.